Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

A man developed skin issues from cancer medication, which improved with specific treatments.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Tofacitinib may help treat severe hair loss, but more research is needed.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib effectively treats Alopecia Areata.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.